NCT05495503 - Tolerance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Post-inflamamatory Hyperpigmentation (PIH). | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 18, 2022

Primary Completion Date

December 14, 2022

Study Completion Date

December 14, 2022

Conditions

Post-inflammatory Hyperpigmentation

Interventions

DEVICE

Prototype (814A-v1)

Application on PIH located on the dorsal area (2 treatments during the study).

DEVICE

Prototype (814B-v1)

Application on PIH located on the dorsal area (2 treatments during the study).

DEVICE

Prototype (814C-v1)

Application on PIH located on the dorsal area (2 treatments during the study).

DEVICE

Prototype (814D-v1)

Application on PIH located on the dorsal area (2 treatments during the study).

Trial Locations (1)

Photobiology Laboratory, Sefako Makgatho Health Sciences University, Pretoria